The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPageGroup Regulatory News (PAGE)

Share Price Information for PageGroup (PAGE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 442.00
Bid: 400.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 41.60 (10.40%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 442.00
PAGE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

14 Mar 2023 12:35

RNS Number : 9451S
PageGroup plc
14 March 2023
 

14 March 2023

 

PageGroup plc (the "Company")

 

Notification of Interests of Directors

 

In accordance with the UK Market Abuse Regulation, notification is hereby given of transactions in the ordinary shares of the Company as follows:

 

The Company's CEO, Nick Kirk, was granted an award in respect of 57,267 ordinary shares of 1p in the Company ("Shares") under a historic incentive plan in March 2020 (being before he became a director and PDMR of the Company). This award was granted subject to a three-year vesting period, with vesting determined by achievement against targets which were set by the Remuneration Committee. Following the Remuneration Committee's consideration of the performance against targets, the award, which is in the form of forfeitable "restricted shares" which have been held by a nominee on Mr Kirk's behalf during the three-year vesting period, vested on 13 March 2023 in respect of 38,178 Shares and the remaining balance (which did not vest) have reverted to the Company's employee benefit trust for nil consideration. Of the Shares which vested, Mr Kirk sold 17,989 Shares to settle his income tax and social security liabilities arising on the vesting of the award. 

 

In March 2022 (also before he became a director and PDMR of the Company), Mr Kirk was granted an award under the Company's Management Incentive Plan ("MIP") in respect of 80,121 Shares. Awards under the MIP vest after three years. Depending on the level of performance achieved against pre-determined targets set by the Remuneration Committee, shares may lapse on the first anniversary of the award, with the remaining shares vesting after a further two years, subject to a continued employment condition. Following an assessment by the Remuneration Committee of the targets set, 16,826 shares have lapsed and reverted to the Company's employee benefit trust for nil consideration. The balance 63,295 will continue to be held by the nominee on behalf of Mr Kirk for the remainder of the vesting period.

 

Following his appointment as CEO, Mr Kirk is required to develop and sustain a shareholding in the Company worth 200% of salary in line with our approved Remuneration Policy. The Remuneration Committee has agreed that Mr Kirk will be required to retain at least half of any shares that vest under historic incentive plans that were awarded and relate to performance prior to his appointment as CEO (after allowing for share sales to settle income tax and social security liabilities that arise).

 

 

Kaye Maguire

General Counsel & Company Secretary

Tel: 020 3077 8069

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Nicholas Kirk

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

PageGroup plc

b)

 

LEI

 

213800JK5ZEQW4AB8G71

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

1p ordinary shares each in PageGroup plc

 

 

ISIN: GB0030232317

b)

 

Nature of the transaction

 

Transfer of unvested shares in respect of the 2020 award under the PageGroup Management Incentive Plan to the trustee of the Michael Page Employees' Benefit Trust

 

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

nil

19,089

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

19,089

nil

 

e)

 

Date of the transaction

 

 

2023-03-13

f)

 

Place of the transaction

 

 

Outside a trading venue

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

1p ordinary shares each in PageGroup plc

 

 

ISIN: GB0030232317

b)

 

Nature of the transaction

 

Sale of shares following the vesting of an award under the PageGroup Management Incentive Plan

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

 

Price(s)

 

Volume(s)

£4.437

17,989

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

17,989

£4.437

e)

 

Date of the transaction

 

 

2023-03-13

f)

 

Place of the transaction

 

 

London Stock Exchange, Main Market (XLON)

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

1p ordinary shares each in PageGroup plc

 

 

ISIN: GB0030232317

b)

 

Nature of the transaction

 

Transfer of unvested shares in respect of the 2022 award under the PageGroup Management Incentive Plan to the trustee of the Michael Page Employees' Benefit Trust

 

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

nil

16,826

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

16,826

nil

 

e)

 

Date of the transaction

 

 

2023-03-13

f)

 

Place of the transaction

 

 

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAADLFDFDEFA
Date   Source Headline
8th Jan 202110:12 amRNSNotice of Q4 and FY 2020 Trading Update
24th Dec 202010:54 amRNSBoard changes
18th Dec 202010:52 amRNSDirector Declaration
8th Dec 20201:06 pmRNSResults of External Audit Tender
7th Dec 20205:35 pmRNSDirector Declaration
14th Oct 20207:00 amRNSThird Quarter Update and COVID-19 Strategy
9th Oct 20201:32 pmRNSNotice of Third Quarter 2020 Trading Update
1st Oct 202010:14 amRNSBlock listing Interim Review
22nd Sep 20209:07 amRNSDirector Declaration
2nd Sep 20209:03 amRNSHolding(s) in Company
17th Aug 20209:45 amRNSHolding(s) in Company
5th Aug 20207:00 amRNSHalf Year Results
9th Jul 20207:00 amRNSSECOND QUARTER, FIRST HALF AND COVID-19 UPDATE
8th Jul 20209:04 amRNSNotice of Second Quarter 2020 Trading Update
4th Jun 20203:36 pmRNSResult of AGM
12th May 202011:03 amRNSNotice of 2020 Q2 Results
7th May 202011:12 amRNSHolding(s) in Company
1st May 202010:30 amRNSChange in Director’s Details
27th Apr 202012:31 pmRNSAnnual Report and Annual General Meeting
8th Apr 20207:00 amRNSFIRST QUARTER AND COVID-19 UPDATE
1st Apr 20203:00 pmRNSTotal Voting Rights
1st Apr 20201:30 pmRNSBlock listing Interim Review
20th Mar 20204:43 pmRNSSecond Price Monitoring Extn
20th Mar 20204:37 pmRNSPrice Monitoring Extension
20th Mar 202011:40 amRNSHolding(s) in Company
18th Mar 20202:24 pmRNSDirector/PDMR Shareholding
16th Mar 20201:12 pmRNSDirector/PDMR Shareholding
16th Mar 20201:09 pmRNSDirector/PDMR Shareholding
10th Mar 202011:59 amRNSHolding(s) in Company
5th Mar 20207:00 amRNSFinal Results
2nd Mar 20201:14 pmRNSTotal Voting Rights
28th Feb 202011:47 amRNSNotice of 2019 Full Year Results
14th Jan 20207:00 amRNSFOURTH QUARTER AND FULL YEAR 2019 TRADING UPDATE
9th Jan 20209:46 amRNSNotice of Q4 and Full Year 2019 Trading Update
2nd Jan 20209:00 amRNSTotal Voting Rights
20th Dec 20198:44 amRNSDirector Declaration
2nd Dec 20191:36 pmRNSTotal Voting Rights
22nd Nov 20191:30 pmRNSDirector/PDMR Shareholding
22nd Nov 20191:04 pmRNSDirector/PDMR Shareholding
8th Oct 20197:00 amRNSTHIRD QUARTER 2019 TRADING UPDATE
2nd Oct 201911:06 amRNSBlock listing Interim Review
2nd Oct 201910:03 amRNSTotal Voting Rights
21st Aug 201910:01 amRNSHolding(s) in Company
16th Aug 20199:59 amRNSHolding(s) in Company
7th Aug 20197:00 amRNSHalf-year Report
1st Aug 20199:19 amRNSNotice of 2019 Half Year Results
17th Jul 20193:26 pmRNSHolding(s) in Company
10th Jul 20197:00 amRNSSecond Quarter and First Half 2019 Trading Update
8th Jul 201912:26 pmRNSNotice of Q2 2019 Trading Update
3rd Jul 20193:22 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.